Clinical and Plasma Proteomic Markers Correlating With Chronic Kidney Disease After Liver Transplantation
Josh Levitsky(Northwestern University), Lorenzo Gallon(University of Illinois Chicago), Robert McDade(Golden Jubilee National Hospital), John J. Friedewald(Northwestern University), Sunil M. Kurian(Scripps Clinic), Michaël Abécassis(University of Arizona), Tony S. Mondala(Scripps Research Institute), S. Gil(Comprehensive Clinical Research), E. Wang(Northwestern University), K Ballard, Steve Horvath(University of California, Los Angeles), D. Salomon(Scripps Research Institute), Peter Langfelder(University of California, Los Angeles)
Cited by 31
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k